Literature DB >> 17307748

Use of mycophenolic acid in non-transplant renal diseases.

Patricia M Stassen1, Cees G M Kallenberg, Coen A Stegeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17307748     DOI： 10.1093/ndt/gfl844

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

1.  Effect of Low-Dose Methotrexate on eGFR and Kidney Adverse Events: A Randomized Clinical Trial.

Authors:  Jeffrey A Sparks; Kathleen M M Vanni; Matthew A Sparks; Chang Xu; Leah M Santacroce; Robert J Glynn; Paul M Ridker; Daniel H Solomon
Journal:  J Am Soc Nephrol       Date:  2021-09-22       Impact factor: 10.121

2.  Severe Relapsing Goodpasture's Disease Successfully Treated with Mycophenolate Mofetil.

Authors:  Anabela Malho; Viriato Santos; Ana Cabrita; Ana Paula Silva; Isabel Pinto; Idalécio Bernardo; Pedro Leão Neves
Journal:  Int J Nephrol       Date:  2010-08-16

3.  Treatment of complicated henoch-schönlein purpura with mycophenolate mofetil: a retrospective case series report.

Authors:  A A Nikibakhsh; H Mahmoodzadeh; M Karamyyar; S Hejazi; M Noroozi; A A Macooie; A Gholizadeh; L Gholizadeh
Journal:  Int J Rheumatol       Date:  2010-06-15

4.  Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment.

Authors:  Muhammad Qasim; Hazir Rahman; Michael Oellerich; Abdul R Asif
Journal:  Proteome Sci       Date:  2011-09-20       Impact factor: 2.480

Review 5.  Development of fungal cell factories for the production of secondary metabolites: Linking genomics and metabolism.

Authors:  Jens Christian Nielsen; Jens Nielsen
Journal:  Synth Syst Biotechnol       Date:  2017-02-28

6.  A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial.

Authors:  Dwarakanathan Ranganathan; George T John; Helen Healy; Matthew J Roberts; Robert G Fassett; Jeffrey Lipman; Paul Kubler; Jacobus Ungerer; Brett C McWhinney; Aaron Lim; Megan Purvey; Reza Reyaldeen; Jason A Roberts
Journal:  BMJ Open       Date:  2013-08-07       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.